AI assistant
Sending…
AIM ImmunoTech Inc. — Director's Dealing 2020
Aug 21, 2020
35334_dirs_2020-08-21_df991c36-0f88-48f6-ae60-2b307e5089cb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AIM ImmunoTech Inc. (AIM)
CIK: 0000946644
Period of Report: 2020-08-21
Reporting Person: EQUELS THOMAS K. (Director, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-08-21 | Common Stock | P | 10730 | $2.33 | Acquired | 171717 | Direct |
More from AIM ImmunoTech Inc.
Share Issue/Capital Change
2026
Jun 11
Governance Information
2026
Jun 10
Capital/Financing Update
2026
Jun 10
Capital/Financing Update
2026
Jun 8
Report Publication Announcement
2026
Jun 4
Capital/Financing Update
2026
May 21
Capital/Financing Update
2026
May 21
Share Issue/Capital Change
2026
May 19
Capital/Financing Update
2026
May 19
Interim / Quarterly Report
2026
May 15